Search Results
Dr. Rogers Discusses Obinutuzumab, Ibrutinib, and Venetoclax Combination in CLL
Dr. Rogers on Benefits of Ibrutinib Combination in CLL
Dr. Rogers Discusses Early Intervention With Ibrutinib in CLL
Dr. Gerson on Venetoclax/Obinutuzumab Combination in CLL
CLL: Venetoclax in combination with obinutuzumab
Four-year follow-up from a Phase II study of obinutuzumab, ibrutinib, and venetoclax in CLL
Long-term follow-up of the GAIA/CLL13 trial: investigating venetoclax-containing combinations in CLL
CLL Latest Treatments: Conversation with Specialist, Dr. Kerry Rogers | The Patient Story
3-year follow-up of obinutuzumab, ibrutinib and venetoclax for CLL
Venetoclax and obinutuzumab combination therapy for CLL
Update on venetoclax for CLL: How low can you go (MRD)?
Dr. Rogers on Determining Patients With High-Risk CLL